Sustainability In The Biotech Industry Statistics 2026

With 2025 momentum, the global green chemistry market is projected to grow 7.0% annually from 2021 to 2027, even as biotech suppliers face harsher realities for emissions, water, and waste. From 55% of plastic waste ending in landfills, incineration, or leakage to widespread Scope 3 measurement and climate disclosure expectations, sustainability progress in biotech is clearly happening but not evenly. This post connects those tensions to the specific market sizes, reporting signals, and investment moves that are reshaping biotech operations.

Key Takeaways

7.0% average annual growth in the global green chemistry market between 2021 and 2027, indicating tailwinds for lower-impact biotech-related manufacturing approaches
$47.6 billion global market size for bio-based chemicals in 2023, highlighting the scale of sustainability-aligned chemical inputs used across biotech supply chains
$1.2 billion global market size for green building materials in 2023, relevant because biotech labs increasingly retrofit facilities for lower energy and emissions
14% of global life science R&D organizations reported budgeted sustainability spend of 1–5% of R&D in 2023, showing current investment levels in sustainability-linked innovation
In 2023, the EU ETS reported carbon prices averaged around €80 per ton CO2, affecting decarbonization cost calculations for biotech operators in covered sectors
25% of packaging is estimated to be recyclable globally at end-of-life, making packaging reduction and redesign efforts a necessity for biotech sustainability
55% of global plastic waste is managed by landfilling, incineration, or leakage due to insufficient collection and recycling, highlighting the environmental risk context for biotech plastic use
2,500+ certified organizations (including life-science firms) are registered under ISO 14001 in the EU as of 2023, supporting adoption of environmental management standards
78% of surveyed life sciences respondents said climate-related reporting is important for their stakeholders, signaling adoption of sustainability disclosure expectations
52% of organizations were actively measuring Scope 3 emissions in 2023 in a supplier engagement survey, reflecting adoption of upstream sustainability accounting
71% of firms in a 2022 survey stated they have a sustainability reporting process, showing organizational adoption of ESG reporting practices used by biotech
The EU’s PRTR threshold for reporting can be as low as 1 tonne/year for some pollutants, enabling quantification of emissions from large industrial sites relevant to biotech plants
In 2021, the pharmaceutical industry accounted for 2.7% of global greenhouse gas emissions from global supply chains (as estimated by a peer-reviewed supply chain footprint analysis), highlighting decarbonization urgency
In 2020, Scope 3 emissions accounted for the majority share of GHG footprints for the average pharmaceutical company in a peer-reviewed footprint study (median share >50% in supply-chain-focused analyses), highlighting upstream impact priority
1.5% of global warming potential (GWP) emissions from the chemical and refining sector are attributed to process emissions in the industrial lifecycle inventory context (used to support decarbonization targets in chemical manufacturing that feeds biotech)

Biotech sustainability is accelerating, driven by market growth, stronger EU rules, and rising Scope 3 reporting.

01 · Category

Market Size15 stats

7.0% average annual growth in the global green chemistry market between 2021 and 2027, indicating tailwinds for lower-impact biotech-related manufacturing approaches

$47.6 billion global market size for bio-based chemicals in 2023, highlighting the scale of sustainability-aligned chemical inputs used across biotech supply chains

$1.2 billion global market size for green building materials in 2023, relevant because biotech labs increasingly retrofit facilities for lower energy and emissions

$6.2 billion global market size for recycling services in 2023, reflecting investment in waste management capacity used by biotech facilities

1.7x increase in global investment in clean technology occurred from 2020 to 2021, providing macro capital flows that biotech sustainability projects can tap into

In the EU, 28% of total final energy consumption came from renewables in 2022, supporting lower-carbon grid power availability for biotech manufacturing

$38.5 billion global market size for bioprocessing equipment in 2023, reflecting the capital base for energy- and solvent-efficient upgrades in biotech manufacturing

The global bioprocessing consumables market was about $20.3 billion in 2022, relevant to sustainability efforts on single-use plastics and reduction programs

$33.3 billion global market size for green and sustainable chemistry in 2023 (measured as products/solutions associated with sustainable chemistry applications)

$12.9 billion global market size for bioremediation in 2023 (measured as products and services in bioremediation)

$6.4 billion global market size for enzymes used in industrial biotechnology in 2023 (industrial enzymes market segment relevant to cleaner processes)

$5.1 billion global market size for bio-based building blocks/chemicals in 2022 (bio-based monomers and intermediates market)

$11.2 billion global market size for microbial genomics and metagenomics in 2022 (applications relevant to biotech R&D enabling more efficient bioprocessing and sustainability monitoring)

$1.6 billion US market for sustainable packaging in 2023 (part of the broader packaging market where biotech often uses secondary/tertiary materials)

1.2% annual average growth in the global microbial fermentation market from 2024 to 2030 (fermentation capacity growth context for scaling sustainable biotech manufacturing)

Interpretation

Market Size Interpretation

For the market size angle, biotech sustainability is riding on a broad, fast-growing commercial base, with the global green chemistry market growing 7.0% annually from 2021 to 2027 and reaching $33.3 billion for green and sustainable chemistry in 2023, signaling real scale and momentum in sustainability-aligned inputs and equipment across biotech supply chains.

02 · Category

Cost Analysis2 stats

14% of global life science R&D organizations reported budgeted sustainability spend of 1–5% of R&D in 2023, showing current investment levels in sustainability-linked innovation

In 2023, the EU ETS reported carbon prices averaged around €80 per ton CO2, affecting decarbonization cost calculations for biotech operators in covered sectors

Interpretation

Cost Analysis Interpretation

In cost analysis terms, with only 14% of global life science R&D organizations budgeting 1 to 5% of R&D for sustainability in 2023 and EU ETS carbon prices averaging about €80 per ton CO2, decarbonization pressures are clear while most biotech investment levels remain comparatively limited.

03 · Category

Industry Trends8 stats

25% of packaging is estimated to be recyclable globally at end-of-life, making packaging reduction and redesign efforts a necessity for biotech sustainability

55% of global plastic waste is managed by landfilling, incineration, or leakage due to insufficient collection and recycling, highlighting the environmental risk context for biotech plastic use

2,500+ certified organizations (including life-science firms) are registered under ISO 14001 in the EU as of 2023, supporting adoption of environmental management standards

Regulatory disclosures: the EU Corporate Sustainability Reporting Directive (CSRD) covers companies with 250+ employees starting in phases beginning in 2024, expanding mandatory sustainability reporting for many biotech firms

The EU taxonomy regulation defines disclosures for environmentally sustainable activities from 2022 onward, affecting capital-market sustainability alignment for biotech investments

The EU Methane Regulation (EU) 2024/1783 requires monitoring and reporting of methane emissions in covered sectors, indirectly increasing scrutiny on biotech supply chains involving energy and gas use

2.6 billion tonnes CO2e were the estimated global emissions associated with methane according to the IPCC, motivating methane leakage control in industrial supply chains used by biotech

Single-use technologies represented about 70% share of bioprocessing in 2021 (reported by industry analyses), indicating the magnitude of plastic footprint-reduction opportunities

Interpretation

Industry Trends Interpretation

Industry trends in biotech sustainability point to urgent packaging and plastics change, because only 25% of global packaging is estimated to be recyclable at end of life while 70% of bioprocessing relied on single use technology in 2021 and 55% of global plastic waste ends in landfills, incineration, or leakage, raising both regulatory and environmental pressure on biotech supply chains.

Sustainability In IndustrySustainability In The Life Sciences Industry Statistics

04 · Category

User Adoption6 stats

78% of surveyed life sciences respondents said climate-related reporting is important for their stakeholders, signaling adoption of sustainability disclosure expectations

52% of organizations were actively measuring Scope 3 emissions in 2023 in a supplier engagement survey, reflecting adoption of upstream sustainability accounting

71% of firms in a 2022 survey stated they have a sustainability reporting process, showing organizational adoption of ESG reporting practices used by biotech

38% of biopharmaceutical companies reported having a science-based target for greenhouse-gas reductions in their sustainability disclosures in 2023, indicating SBTi adoption relevant to biotech

24% of pharmaceutical companies indicated they had targets specifically for water use reduction in sustainability reports (2019–2022 aggregation), showing adoption of water stewardship

More than 6,000 organizations disclosed climate targets or actions through CDP in 2023, indicating broad adoption of standardized sustainability disclosure used by many biotech firms

Interpretation

User Adoption Interpretation

User adoption in biotech is accelerating as 78% of respondents say climate-related reporting is important and over 6,000 organizations used CDP to disclose climate targets or actions in 2023, showing sustainability disclosure expectations are becoming mainstream.

05 · Category

Performance Metrics5 stats

The EU’s PRTR threshold for reporting can be as low as 1 tonne/year for some pollutants, enabling quantification of emissions from large industrial sites relevant to biotech plants

In 2021, the pharmaceutical industry accounted for 2.7% of global greenhouse gas emissions from global supply chains (as estimated by a peer-reviewed supply chain footprint analysis), highlighting decarbonization urgency

In 2020, Scope 3 emissions accounted for the majority share of GHG footprints for the average pharmaceutical company in a peer-reviewed footprint study (median share >50% in supply-chain-focused analyses), highlighting upstream impact priority

A 2022 peer-reviewed study found that biopharmaceutical manufacturing can produce wastewater with measurable chemical oxygen demand (COD) requiring advanced treatment, supporting the measurable need for effluent impact controls

In 2021, the EU reported 45% of pharmaceutical residues in wastewater were still detected despite treatment effectiveness improvements, illustrating ongoing measurable environmental release risk

Interpretation

Performance Metrics Interpretation

Performance metrics show that sustainability pressure in biotech is measurable and persistent, with Scope 3 emissions making up over half of the average pharmaceutical company’s GHG footprint and EU wastewater still detecting 45% of pharmaceutical residues in 2021 despite treatment improvements.

06 · Category

Environmental Performance2 stats

1.5% of global warming potential (GWP) emissions from the chemical and refining sector are attributed to process emissions in the industrial lifecycle inventory context (used to support decarbonization targets in chemical manufacturing that feeds biotech)

3.7% of global final energy consumption was in the chemical sector in 2019 (energy intensity context for decarbonizing inputs used in biomanufacturing)

Interpretation

Environmental Performance Interpretation

From an Environmental Performance perspective, reducing industrial process emissions and energy demand upstream matters because chemical and refining process emissions account for 1.5% of global warming potential and the chemical sector used 3.7% of global final energy in 2019, both of which directly influence the carbon footprint of inputs to biotech manufacturing.

Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA

Felix Zimmermann. (2026, February 13). Sustainability In The Biotech Industry Statistics. Gitnux. https://gitnux.org/sustainability-in-the-biotech-industry-statistics

MLA

Felix Zimmermann. "Sustainability In The Biotech Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/sustainability-in-the-biotech-industry-statistics.

Chicago

Felix Zimmermann. 2026. "Sustainability In The Biotech Industry Statistics." Gitnux. https://gitnux.org/sustainability-in-the-biotech-industry-statistics.